Background/objective/methods: Glutathione-S-transferase Mu1 () and glutathione peroxidase 1 () are known antioxidant enzymes that help protect cells from the oxidative damage that occurs from smoking. This study explored the correlation between and levels between a group of smokers with the and genes in the Saudi population and a control group and investigated the genetic risk factors in the group of smokers.
Results: The control and smokers' group ( = 50; aged 22.3 ± 3.1 years; BMI 24.6 ± 5.9 kg/m) were genotyped using quantitative polymerase chain reaction (qPCR). In comparison with the control group, the smokers' group displayed a different genotype disruption of and . Carriers of the homozygous (TT) genotype of had more than a twofold (OR = 2.71, 95% CI = 0.10-70.79, = 1.000) smoking risk than the carriers of the heterozygous (CT) genotype. Those with the gene showed no risk in the control and smokers' groups. Smokers with the TT/GG combination (homozygous for and normal for ) were identified as high risk (OR = 2.58, 95% CI = 0.096-69.341).
Conclusion: The main outcomes showed no significant association between genetic polymorphism of the and genes and cigarette smoking in the Saudi Arabian population. However, the results showed a slight decrease in the number of and gene modifications among smokers.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10790742 | PMC |
http://dx.doi.org/10.4103/jpbs.jpbs_365_23 | DOI Listing |
Cureus
December 2024
Department of Surgery, College of Medicine, University of Bisha, Bisha, SAU.
Background Cancer is a major cause of morbidity and mortality worldwide. It is anticipated that the number of new cases in Saudi Arabia will increase yearly as a result of significant changes in lifestyle and population development. There is little to no information or studies concerning cancer awareness or knowledge among the residents of Bisha Province.
View Article and Find Full Text PDFJ Res Med Sci
November 2024
Department of Medical Laboratory Technology, University of Tabuk, Tabuk, Saudi Arabia.
Background: The study aimed to detect the association between insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) and interleukin-6 (IL-6) polymorphisms among type 2 diabetes mellitus (T2DM).
Materials And Methods: This study involved 500 individuals; 250 obese DM cases and 250 healthy controls. The polymerase chain reaction restriction fragment length polymorphism was used to identify the genotype of the IGF2BP2 gene for the small nucleoproteins rs4402960 (G>T) and small nucleoproteins rs800795 (G>C).
Anatol J Cardiol
January 2025
Department of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Background: Type 2 diabetes mellitus (T2DM) patients with small-diameter stents (SDS), that are equal to or less than 2.5 mm in diameter, face increased risks of restenosis and complications. This study aimed to evaluate the 1-year follow-up to assess the rate of major adverse cardiac events (MACE) and bleeding risk between ticagrelor and clopidogrel in T2DM patients after SDS implantation.
View Article and Find Full Text PDFBMC Public Health
January 2025
Biochemistry Department, College of Science, King Saud University, Riyadh, 11451, Saudi Arabia.
Background: Over 390 million children and adolescents are affected by overweight and obesity worldwide. Similarly, obesity rates are rising in these age groups in the Middle East and Gulf region including Saudi Arabia. Dietary habits are fundamental in childhood overweight and obesity management.
View Article and Find Full Text PDFJ Clin Immunol
January 2025
Population Health Sciences Institute, Newcastle University, Newcastle-Upon-Tyne, UK.
Receptor Interacting Serine/Threonine Kinase 1 (RIPK1) is widely expressed and integral to inflammatory and cell death responses. Autosomal recessive RIPK1-deficiency, due to biallelic loss of function mutations in RIPK1, is a rare inborn error of immunity (IEI) resulting in uncontrolled necroptosis, apoptosis and inflammation. Although hematopoietic stem cell transplantation (HSCT) has been suggested as a potential curative therapy, the extent to which disease may be driven by extra-hematopoietic effects of RIPK1-deficiency, which are non-amenable to HSCT, is not clear.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!